Wellington Management Group LLP Decreases Position in Zoetis Inc. $ZTS

Key Points

• Wellington Management Group LLP reduced its stake in Zoetis by 3.9%, selling 348,257 shares and leaving 8,541,423 shares (about 1.94% of the company) valued at roughly $1.25 billion.
• Zoetis beat quarterly expectations with $1.48 EPS (vs. $1.40 est.) and $2.39 billion revenue, and set FY2026 guidance of 7.00–7.10 EPS; the company has a market cap of about $48.8 billion and a P/E of 19.2.
• Zoetis declared a quarterly dividend of $0.53 per share (annualized $2.12, ~1.8% yield) and holds a consensus analyst rating of "Hold" with a $152.91 price target.

Wellington Management Group LLP decreased its holdings in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 3.9% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 8,541,423 shares of the company's stock after selling 348,257 shares during the period. Wellington Management Group LLP owned approximately 1.94% of Zoetis worth $1,249,781,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of ZTS. North Star Asset Management Inc. grew its holdings in shares of Zoetis by 4.9% during the second quarter. North Star Asset Management Inc. now owns 1,441 shares of the company's stock valued at $225,000 after buying an additional 67 shares during the last quarter. Bank of Nova Scotia Trust Co. increased its holdings in shares of Zoetis by 4.6% in the second quarter. Bank of Nova Scotia Trust Co. now owns 1,692 shares of the company's stock valued at $264,000 after purchasing an additional 74 shares during the period. Summit Place Financial Advisors LLC raised its stake in shares of Zoetis by 0.4% in the third quarter. Summit Place Financial Advisors LLC now owns 19,369 shares of the company's stock worth $2,834,000 after purchasing an additional 76 shares during the last quarter. First County Bank CT lifted its holdings in shares of Zoetis by 5.4% during the third quarter. First County Bank CT now owns 1,535 shares of the company's stock worth $225,000 after purchasing an additional 79 shares during the period. Finally, CWA Asset Management Group LLC increased its holdings in Zoetis by 1.1% in the 3rd quarter. CWA Asset Management Group LLC now owns 7,236 shares of the company's stock worth $1,059,000 after buying an additional 80 shares during the period. Institutional investors and hedge funds own 92.80% of the company's stock.

Zoetis Trading Up 0.1%

Shares of Zoetis stock opened at $115.62 on Friday. The company has a current ratio of 3.03, a quick ratio of 1.94 and a debt-to-equity ratio of 2.71. Zoetis Inc. has a twelve month low of $114.47 and a twelve month high of $172.23. The firm has a market capitalization of $48.81 billion, a PE ratio of 19.21, a P/E/G ratio of 1.76 and a beta of 0.95. The firm's 50-day moving average price is $125.34 and its 200 day moving average price is $131.91.

Zoetis (NYSE:ZTS - Get Free Report) last announced its earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.08. The business had revenue of $2.39 billion during the quarter, compared to analysts' expectations of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business's revenue was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be given a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. Zoetis's payout ratio is presently 35.22%.

Analyst Ratings Changes

Several research firms have recently commented on ZTS. William Blair reaffirmed an "outperform" rating on shares of Zoetis in a report on Monday, March 2nd. UBS Group set a $136.00 price target on shares of Zoetis in a report on Thursday, January 29th. Bank of America boosted their price objective on Zoetis from $135.00 to $140.00 and gave the company a "neutral" rating in a report on Friday, February 13th. HSBC set a $140.00 target price on Zoetis in a report on Wednesday, December 10th. Finally, Leerink Partners restated a "market perform" rating on shares of Zoetis in a research report on Tuesday. Six equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $152.91.

Zoetis Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.